Category: PTSD

Symposium

Symposium 55 - Beyond PTSD: Far-Reaching Effects of Exposure-Based PTSD Treatment on Common Clinical Complexities

Friday, November 17
3:30 PM - 5:00 PM
Location: Sapphire Ballroom B, Level 4, Sapphire Level

Keywords: PTSD (Posttraumatic Stress Disorder) | Exposure | Comorbidity
Presentation Type: Symposium

Exposure-based therapies are highly efficacious in the treatment of PTSD (Powers, Halpern, Ferenschak, Gillihan, & Foa, 2010; Sloan, Marx, Bovin, Feinstein, & Gallagher, 2012), yet concerns abound about the use of these treatments in complex clinical cases (Becker, Zayfert, & Anderson, 2004; van Minnen, Hendriks, & Olff, 2010). These concerns center around the belief that common clinical complexities may interfere with exposure-based treatments and that associated features of PTSD may not resolve without interventions that explicitly target them (Cloitre, 2015). Examining the effect of co-occurring problems on PTSD treatment outcomes, as well whether exposure-based PTSD treatments successfully reduce these problems, is therefore important for both therapists and patients alike.


This symposium will include data from four randomized controlled trials conducted in diverse clinical settings and will specifically highlight the effects of exposure-based PTSD treatment on secondary outcomes. The first presentation will examine the influence of high levels of pre-treatment guilt on PTSD outcomes in post-9/11 active duty military personnel with primary PTSD, as well as whether prolonged exposure therapy is effective at reducing guilt compared to non-exposure-based PTSD treatment. In the second talk, latent associations between PTSD and depression symptom clusters within a civilian sample will be presented, with a focus on how these profiles relate to change in PTSD and depression following treatment with either prolonged exposure or sertraline. The third talk will explore whether prolonged exposure therapy leads to improvements in emotional and behavioral problems among adolescents seeking treatment for sexual abuse-related PTSD in a community mental health setting. Finally, the last presentation will examine whether group cognitive behavioral therapy, relative to group present centered therapy, results in reductions in depression, anxiety, and harmful alcohol use among male veterans with PTSD. Dr. Edna Foa, the developer of prolonged exposure therapy and an expert in PTSD and exposure therapies, will summarize key findings and their implications for future research.

Learning Objectives:

Alissa B. Jerud

Postdoctoral Fellow
University of Pennsylvania, Center for the Treatment and Study of Anxiety

Presentation(s):

Send Email for Alissa Jerud

Edna Foa

Professor and Director
University of Pennsylvania. Center for the Treatment and Study of Anxiety

Presentation(s):

Send Email for Edna Foa

Carmen McLean

Assistant Professor
University of Pennsylvania, Center for the Treatment and Study of Anxiety

Presentation(s):

Send Email for Carmen McLean

Lori A. Zoellner

Professor
University of Washington

Presentation(s):

Send Email for Lori Zoellner

Laurie Zandberg

Assistant Professor
University of Pennsylvania, Center for the Treatment and Study of Anxiety

Presentation(s):

Send Email for Laurie Zandberg

Denise M. Sloan

Associate Director
National Center for PTSD, VA Boston Healthcare System

Presentation(s):

Send Email for Denise Sloan


Assets

Symposium 55 - Beyond PTSD: Far-Reaching Effects of Exposure-Based PTSD Treatment on Common Clinical Complexities



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Beyond PTSD: Far-Reaching Effects of Exposure-Based PTSD Treatment on Common Clinical Complexities